What are the methods for screening for fetal malpresentation (abnormal fetal position)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: March 27, 2025 • View editorial policy

From the Guidelines

Screening for fetal malpresentation should be performed routinely in the third trimester, particularly at 36 weeks gestation, through clinical examination (Leopold's maneuvers) and confirmed with ultrasound when suspected, as recommended by the American College of Radiology in their 2021 guidelines 1. The methods for screening for fetal malpresentation include:

  • Clinical examination (Leopold's maneuvers) to assess fetal presentation during prenatal visits in the third trimester
  • Ultrasound confirmation when malpresentation is suspected, with a focus on transabdominal anatomy scans for low-risk pregnancies and transabdominal detailed scans for high-risk pregnancies 1
  • Identification of risk factors for malpresentation, such as uterine anomalies, fibroids, placenta previa, multiple gestation, or polyhydramnios, to guide the screening process The American College of Radiology recommends that ultrasound screening be performed at least once during pregnancy, with evidence showing increased detection of fetal anomalies and improved detection of multiple gestations without detrimental effects on cognitive or physical development 2. Ultrasound screening, particularly transabdominal anatomy scans, is usually appropriate for initial second and third trimester screening for fetal anomaly in low-risk pregnancies, and transabdominal detailed scans are usually appropriate for high-risk pregnancies 1. It is essential to note that early detection of malpresentation allows time for potential interventions like external cephalic version (ECV), which can reduce the need for cesarean delivery and associated maternal morbidity, while ensuring appropriate delivery planning for cases where the malpresentation persists.

From the Research

Methods for Screening Fetal Malpresentation

The following methods are used for screening fetal malpresentation:

  • Intrapartum ultrasound to assess fetal position and presentation 3
  • Digital examination to assess malpresentation and malposition, although intrapartum ultrasound has been found to be more reliable 3
  • External cephalic version (ECV) as a procedure to manually maneuver the fetus to cephalic position, allowing patients to attempt vaginal birth 4, 5, 6

Diagnosis and Management

Diagnosis of fetal malpresentation is necessary for appropriate management, which includes:

  • Accurate diagnosis of fetal malpresentation and malposition 7
  • Management options such as cesarean section (CS) or external cephalic version (ECV) 4, 5
  • Consideration of risk factors such as multiparity, previously affected pregnancy, polyhydramnios, and fetal and uterine anomalies 5

Additional Methods

Additional methods that may be valuable in managing fetal malpresentation include:

  • Chiropractors, acupuncture, and moxibustion as identified by patients as valuable additional methods of malpresentation management 4

References

Guideline

acr appropriateness criteria® second and third trimester screening for fetal anomaly.

Journal of the American College of Radiology, 2021

Guideline

acr appropriateness criteria® second and third trimester screening for fetal anomaly.

Journal of the American College of Radiology, 2021

Research

Intrapartum ultrasound for the diagnosis of cephalic malpositions and malpresentations.

American journal of obstetrics & gynecology MFM, 2021

Research

Management of fetal malpresentation.

Clinical obstetrics and gynecology, 2015

Research

External cephalic version.

Journal of nurse-midwifery, 1993

Research

Fetal Malpresentation and Malposition: Diagnosis and Management.

Obstetrics and gynecology clinics of North America, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.